Retinal Dystrophy Due to Biallelic ABCA4 Mutations

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Retinal Dystrophy Due to Biallelic ABCA4 Mutations trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT07002398

Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease…

This is a single-arm, open-label, non-randomized, single dose-escalation, first-in-human (FIH) clinical trial to evaluate the safety and preliminary efficacy of…

China15 participantsStarted 2024-12-23

Treatment: VG801

Retinal Dystrophy Due to Biallelic ABCA4 Mutations

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease…

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease…

All recent trials (1 shown)